SynBioBeta Speaker

Kid Parchariyanon

SeaX Ventures.

Managing Partner

Dr. Kid Parchariyanon, a former physician turned entrepreneur and venture capitalist. He is the Managing Partner of SeaX Ventures, a US-based DeepTech VC fund that invests in exponential technologies globally. SeaX Ventures has backed several Synbio and Life Sciences startups like Hoxton Farms, Bluu Seafood and Cambrium, just to name a few.He is also the CEO and Co-Founder of RISE, one of the largest open innovation platforms in Southeast Asia that partners with corporates and governments to drive 1% of GDP growth while reducing 1% of global carbon emissions. He has supported the launch of more than 2,000 startups, including two unicorns.Dr. Kid is passionate about leveraging technology to solve the world’s biggest challenges, especially in the fields of DeepTech and sustainability. With an MD from Mahidol University and an MS in Biomedical Informatics from Oregon Health and Science University, Dr. Kid has a deep passion and a strong belief in the transformative potential of emerging technologies—such as AI, climate tech and life sciences.He has been recognized as Stanford’s GSB Alumni Catalyst, Gen.T List Honoree, Tatler’s The Futurist, Prestige’s 40 Under 40, and Eisenhower Fellow.

SynBioBeta 2026 Tickets are Live

Confirmed Speakers

Sessions Featuring

Kid

This Year

TBD

Session lineup still growing

Purchase Pass

Featuring

Speaker Coming Soon

Fireside Chat

12:00 AM

-

8:30 AM

Human Health

From Cells to Patients: Solving the Scale Mismatch in Virtual Biology

Drug discovery often measures biology at the cell level while interventions work at the tissue, organ, or whole-patient scale. This mismatch can make accurate cell-level predictions irrelevant in the clinic. This session dives into strategies to bridge that gap: multiscale modeling that nests single-cell dynamics within organ-level simulations, spatial transcriptomics that preserve context, and surrogate models that translate cell-level outputs into clinical biomarkers. Speakers will ask: how do we ensure virtual biology reflects not just what cells do in isolation, but how biology behaves in the real complexity of patients?

Purchase Pass

Featuring

Speaker Coming Soon

Previous Speakers Include